Peripheral expression of Jak3 is required to maintain T lymphocyte function

Journal of Experimental Medicine

Volumn 185, Issue 2, 1997, Pages 197-206

  Thomis, Daniel C ^a   Berg, Leslie J ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL MATURATION; GENE EXPRESSION REGULATION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; HOMOZYGOTE; HUMANS; IMMUNOPHENOTYPING; JANUS KINASE 3; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTAGENESIS, SITE-DIRECTED; PHENOTYPE; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES;

EID: 0031054442     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.2.197     Document Type: Article

References (53)

1. Fehling, H.J., A. Krotkova, C. Saintruf, and H. von Boehmer. 1995. Crucial role of the pre-T cell receptor alpha gene in development of alpha-beta but not gamma-delta T cells. Nature (Lond.). 378:419-422.
2. Blackman, M., J. Kappler, and P. Marrack. 1990. The role of the T cell receptor in positive and negative selection of developing T cells. Science (Wash. DC). 248:1335-1341.
3. Anderson, G., E.J. Jenkinson, N.C. Moore, and J.J.T. Owen. 1993. MHC class II positive epithelium and mesenchyme cells are both required for T cell development in the thymus. Nature (Lond.). 362:70-73.
4. Peschon, J.J., P.J. Morrissey, K.H. Grabstein, F.J. Ramsdell, E. Maraskovsky, B.C. Gliniak, L.S. Park, S.F. Ziegler, D.E. Williams, C.B. Ware, J.D. Meyer, and B.L. Davison. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp. Med. 180:1955-1960.
5. von Freeden-Jeffry, U., P. Vieira, L.A. Lucian, T. McNeil, S.E.G., Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-1526.
6. + thymic selection in humans lacking zap-70 kinase. Cell. 76: 947-958.
7. Chan, A.C., T.A. Kadlecek, M.E. Elder, A.H. Filipovich, W.-L. Kuo, M. Iwashima, T.G. Parslow, and A. Weiss. 1994. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science. 264:1599-1601.
8. Elder, M.E., D. Lin, J. Clever, A.C. Chan, T.J. Hope, A. Weiss, and T.G. Parslow. 1994. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science (Wash. DC). 264:1596-1599.
9. Straus, D.B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 70:585-593.
10. Stein, P.L., H.-M. Lee, S. Rich, and P. Soriano. 1992. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell. 70:741-750.
11. Appleby, M.W., J.A. Gross, M.P. Cooke, S.D. Levin, X. Qian, and R.M. Perlmutter. 1992. Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell. 70:571-763.
12. Tarakhovsky, A., M. Turner, S. Schaal, P.J. Mee, L.P. Duddy, K. Rajewsky, and V.L.J. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature (Lond.). 374:467-470.
13. + thymocytes. Nature (Lond.). 374:474-477.
14. Zhang, R., F.W. Alt, L. Davidson, S.H. Orkin, and W. Swat. 1995. Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature (Lond.). 374:470-473.
15. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fata multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
16. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science (Wash. DC). 270:985-988.
17. Willerford, D.M., J.Z. Chen, J.A. Ferry, L. Davidson, A. Ma, and F.W. Alt. 1995. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3:521-530.
18. Suzuki, H., T.M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J.J.L. Sirnard, P.S. Ohashi, H. Griesser, T. Taniguchi, C.J. Paige, and T.W. Mak. 1995. Deregulated T cell activation and autoimmumty in mice lacking interleukin-2 receptor beta. Science (Wash. DC). 268:1472-1476.
19. Cao, X., E.W. Shores, J. Hu-Li, M.R. Anver, B.L. Kelsall, S.M. Russell, J. Drago, M. Noguchi, A. Grinberg, E.T. Bloom, W.E. Paul, S.I. Katz, P.E. Love, and W.J. Leonard. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity. 2:223-238.
20. DiSanto, J.P., W. Müller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc. Natl. Acad. Sci. USA. 92:377-381.
21. Noguchi, M., H. Yi, H.M. Rosenblatt, A.H. Filipovich, S. Adelstein, W.S. Modi, O.W. McBride, and W.J. Leonard. 1993. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 73:147-157.
22. Russell, S.M., N. Tayebi, H. Nakajima, M.C. Riedy, J.L. Roberts M. Javad Aman, T.-S. Migone, M. Noguchi, M.L. Markert, R.H. Buckley, J.J. O'Shea, and W.J. Leonard. 1995. Mutation of JAK3 in a patient with SCID: essential role of JAK3 in lymphoid development. Science (Wash. DC). 270:797-800.
23. Macchi, P., A. Villa, S. Giliani, M.G. Sacco, A. Frattini, F. Porta, A.G. Ugazio, J.A. Johnston, F. Candotti, J.J. O'Shea, P. Vezzoni, and L.D. Notarangelo. 1995. Mutations of JAK3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (Lond.). 377:65-68.
24. Nosaka, T., J.M.A. van Deursen, R.A. Tripp, W.E. Thierfelder, B.A. Witthuhn, A.P. McMickle, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1995. Defective lymphoid development in mice lacking JAK3. Science (Wash. DC). 270:800-802.
25. Park, S.Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, N. Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T. Saito. 1995. Developmental defects of lymphoid cells in JAK3 kinase-deficient mice. Immunity. 3:771-782.
26. Thomis, D.C., C.B. Gurniak, E. Tivol, A.H. Sharpe, and L.J. Berg. 1995. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking JAK3. Science (Wash. DC). 270:794-797.
27. Giri, J.G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, S. Namen, L.S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO (Eur. Mol. Biol. Organ.) J. 13:2822-2830.
28. Kondo, M., T. Takeshita, M. Higuchi, M. Nakamura, T. Sudo, S.-I. Nishikawa, and K. Sugamura. 1994. Functional participation of the IL-2 receptor γ chain in 1L-7 receptor complexes. Science (Wash. DC). 263:1453-1454.
29. Kondo, M., T. Takeshita, N. Ishii, M. Nakamura, S. Watanabe, K. Arai, and K. Sugamura. 1993. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science (Wash. DC). 262:1874-1877.
30. Russell, S.M., A.D. Keegan, N. Harada, Y. Nakamura, M. Noguchi, P. Leland, M.C. Friedmann, A. Miyajima, R.K. Puri, W.E. Paul, and W.J. Leonard. 1993. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science (Wash. DC). 262:1880-1883.
31. Noguchi, M., Y. Nakamura, S.M. Russell, S.F. Ziegler, M. Tsang, X. Cao, and W.J. Leonard. 1993. Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science (Wash. DC). 262:1877-1880.
32. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (Lond.). 352:621-624.
33. Gurniak, C.B., and L.J. Berg. 1996. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells. Blood. 87:3151-3160.
34. Chaffin, K.E., C.R. Beals, K.A. Forbush, T.M. Wilkie, M.I. Simon, and R.M. Perlmutter. 1990. Dissection of thymocyte signaling pathways by in vivo expression of pertussin-toxin ADP ribosyltransferase. EMBO (Eur. Mol. Biol. Organ.) J. 9: 3821-3829.
35. Hogan, B., F. Constantini, and E. Lacy. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
36. Garvin, A.M., K.M. Abraham, K.A. Forbush, R. Peet, A.G. Farr, and R.M. Perlmutter. 1990. Disruption of thymocyte development by SV40 T antigen. Int. Immunol. 2:173-180.
37. Abraham, K.M., S.D. Levin, J.D. Marth, K.A. Forbush, and R.M. Perlmutter. 1991. Delayed thymocyte development induced by augmented expression of p561ck. J. Exp. Med. 173: 1421-1432.
38. Abraham, K.M., S.D. Levin, J.D. Marth, K.A. Forbush, and R.M. Perlmutter. 1991. Thymic tumorigenesis induced by overexpression of p561ck. Proc. Natl. Acad. Sci. USA. 88: 3977-3981.
39. Alberola-Ila, J., K.A. Forbush, R. Seger, E.g., Krebs, and R.M. Perlmutter. 1995. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (Lond.). 373:620-62.3.
40. Allen, J.M., K.A. Forbush, and R.M. Perlmutter. 1992. Functional dissection of the Lck proximal promoter. Mol. Cell. Biol. 12:2758-2768.
41. Cooke, M.P., K.M. Abraham, K.A. Forbush, and R.M. Perlmutter. 1991. Regulation of T cell receptor signaling by a src family protein tyrosine kinase (p59fyn). Cell. 65:281-291.
42. Teh, H.-S., A.M. Garvin, K.A. Forbush, D.A. Carlow, C.B. Davis, D.R. Littman, and R.M. Perlmutter. 1991. Participation of CD4 coreceptor molecules in T cell repertoire selection. Nature (Lond.). 349:241-243.
43. Hanks, S.K., A.M. Quinn, and T. Hunter. 1988. The protein tyrosine kinase family: conserved features and deduced phylogeny of the catalytic domains. Science (Wash. DC). 241:42-52.
44. Kawamura, M., D.W. McVicar, J.A. Johnston, T.B. Blake, Y.-Q. Chen, B.K. Lal, A.R. Lloyd, K.J. Kelvin, J.E. Staples, J.R. Ortaldo, and J.J. O'Shea. 1994. Molecular cloning of L-JAK, a Janus family protein tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc. Natl. Acad. Sci. USA. 91:6374-6378.
45. c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (Wash. DC). 266:1042-1045.
46. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z.-J. Liu, I. Oishi, O. Silvennoinen, B. Witthuhn, J.N. Ihle, and T. Taniguchi. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science (Wash. DC). 266:1045-1047.
47. Briscoe, J., N.C. Rogers, B.A. Witthuhn, D. Watling, A.G. Harpur, A. Wilks, G.A. Stark, J.N. Ihle, and I.M. Kerr. 1996. Kinase-negative mutants of Jak1 can sustain interferon-γ-inducible gene expression but not an antiviral state. EMBO (Eur. Mol. Biol. Organ.) J. 15:799-899.
48. Sanchez, M.J., M.O. Muench, M.G. Roncarolo, L.L. Lanier, and J.H. Phillips. 1994. Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180:569-576.
49. Lanier, L.L., H. Spits, and J.H. Phillips. 1992. The developmental relationship between NK cells and T cells. Immunol. Today. 13:392-395.
50. Brooks, E.G., F.C. Schmalstieg, D.P. Wirt, H.M. Rosenblatt, L.T. Adkins, D.P. Lookingbill, H.E. Rudloff, T.A. Rakusan, and A.S. Goldman. 1990. A novel X-linked combined immunodeficiency disease. J. Clin. Invest. 86:1623-1631.
51. Nakajima, H., E.W. Shores, M. Noguchi, and W.J. Leonard. The common cytokine receptor γ chain plays an essential role in regulating lymphoid homeostasis J. Exp. Med. 185: 189-195.
52. DeSilva, D.R., K.B. Urdahl, and M.K. Jenkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261-3267.
53. c chain of the IL-2 receptor. Science (Wash. DC). 266:1039-1042.